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Model	  inputs	  
QALY	  es(mates	  are	  derived	  from	  the	  literature	  (Lidgren	  et	  al,	  2007).	  
The	  following	  health	  states	  were	  iden(fied:	  






Transi(on	   probabili(es	   (λ1,	   λ2,	   λ3)	   were	   es(mated	   from	   Adjuvant!	  
and	   IBTR!.	   The	   transi(on	   probabili(es	   were	   adapted	   to	   obtain	  
cumula(ve	  distribu(on	  func(ons	  for	  the	  risk	  using	  three	  criteria:	  (1)	  
age,	   (2)	   tumor	  size	  and	  (3)	   lymph	  node	   involvement.	  Es(mates	   for	  









Assump/ons	  for	  the	  effect	  of	  follow-­‐up	  programs	  
•  Surgeon	  and	  nurse-­‐prac((oner	  follow	  up	  perform	  equal	  in	  terms	  
of	  detec(ng	  recurrences;	  
•  Telephone	   consulta(on	   is	   assumed	   to	   be	   not-­‐effec(ve	   for	  
detec(on	  of	  recurrences	  (probability	  =	  0).	  	  
•  The	  effect	  of	  adjuvant	  therapy	  is	  modeled	  in	  the	  risk	  rates;	  
•  Regarding	  the	  probability	  of	  detec(ng	  a	  recurrence	  we	  used	  the	  
following	  assump(ons:	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Objec/ves	  
About	  one	  in	  every	  eight	  women	  develops	  breast	  cancer.	  	  
In	  the	  Netherlands,	  11,000	  new	  cases	  are	  registered	  every	  year	  and	  
about	  3500	  women	  die	  of	  breast	  cancer.	  According	  to	  the	  guidelines	  
(www.oncoline.nl	   for	   the	  Netherlands)	  most	  pa(ents	  are	  currently	  
assigned	   the	   same	   follow	  up,	   i.e.	  five	  years	   long,	   two	  consults	  per	  
year.	  It	  was	  inves(gated	  whether	  a	  less	  intensive	  follow-­‐up	  scheme	  
may	  be	  more	  appropriate.	  	  	  
Conclusion	  
•  In	   general,	   we	   can	   conclude	   that	   young	   pa(ents	   (<50)	  
require	   a	   more	   intensive	   follow-­‐up	   than	   older	   pa(ents	  
(>70).	   Older	   pa(ents	   have	   a	   lower	   life	   expectancy,	   and	  
therefore	   there	   are	   less	   QALYs	   to	   be	   gained	   and	   the	  
effec(veness	  of	  follow-­‐up	  is	  lower.	  
•  Pa(ents	   with	   (very)	   unfavorable	   tumor	   characteris(cs	  
s(ll	  benefit	  from	  follow-­‐up.	  
•  The	  number	  of	  consults	  can	  be	  reduced	  drama(cally	  by	  
switching	  to	  an	  individualized	  follow-­‐up.	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Discrete-­‐Event	  Simula/on	  
Discrete-­‐event	   simula(on	  was	  used	   to	   calculate	   the	  most	   efficient	  
use	  of	  workforce	  alloca(on.	   Tecnoma(x	  Plant	   Simula(on	   sofware	  

















The	   simula(on	   starts	   with	   the	   crea(on	   of	   pa(ent	   groups	   of	   1000	  
pa(ents	   each.	   For	   each	   pa(ent	   group	   300	   runs	   were	   simulated.	  
Assuming	   three	   criteria,	   120	   different	   pa(ent	   groups	   were	  
iden(fied.	   The	   simula(on	   starts	   with	   the	   genera(on	   of	   disease	  
processes	  for	  each	  individual	  pa(ent.	  Simula(on	  con(nues	  un(l	  all	  













Kimman	  et	  al	  (Eur.	  J.	  Cancer,	  2011)	  
One-­‐year	  cost-­‐effec(veness	  of	  four	  follow-­‐up	  scenarios:	  	  
hospital	   follow-­‐up;	   (2)	   nurse-­‐led	   telephone	   follow-­‐up;	   (3)	   hospital	  
follow-­‐up	  plus	  educa(onal	  group	  program	  (EGP);	  and	  (4)	  nurse-­‐led	  
telephone	   follow-­‐up	  plus	   EGP.	  Nurse-­‐led	   telephone	   follow-­‐up	  plus	  
EGP	  seems	  an	  appropriate	  and	  cost-­‐effec(ve	  alterna(ve	  to	  hospital	  
follow-­‐up	  for	  breast	  cancer	  pa(ents	  during	  their	  first	  year.	  	  
Kimman	  et	  al	  (Acta	  Oncol,	  2010)	  
The	   medical	   specialist	   was	   the	   most	   preferred	   to	   perform	   the	  
follow-­‐up,	   but	   a	   combina(on	   of	   the	  medical	   specialist	   and	   breast	  
care	  nurse	  alterna(ng	  was	  also	  acceptable	  to	  pa(ents.	  Face-­‐to-­‐face	  
contact	   was	   strongly	   preferred	   to	   telephone	   contact.	   Follow-­‐up	  
visits	  every	  three	  months	  were	  preferred	  over	  visits	  every	  four,	  six,	  
or	  12	  months.	  
Robertson	  et	  al	  (HTA,	  2011)	  
Combining	   ini(a(on,	   frequency	   and	   dura(on	   of	   surveillance	  
mammography	   resulted	   in	   54	   differing	   surveillance	   regimens	   for	  
women	   afer	   BCS	   and	   56	   for	   women	   following	   mastectomy.	   The	  
studies	   included	   in	   the	   clinical	   effec(veness	   review	   suggest	  
surveillance	  mammography	  offers	  a	  survival	  benefit.	  
create	  pa(ents	  
(1000	  pa(ents,	  300	  runs)	  
Generate	  disease	  
process	  per	  pa(ent	  
Increase	  (me	  with	  
one	  year	  
Set	  age,	  tumor	  size	  and	  
lymph	  node	  status	  
according	  to	  pa(ent	  group	  
Start	  simula(on	  
Repeat	  un(l	  all	  




from	  other	  causes	  
(λ5)	  
Move	  pa(ent	  to	  
other	  health	  states	  
because	  of	  BC	  events	  
Every	  year	  
Generate	  local	  
recurrence	  and	  (me	  
of	  event	  (λ1	  and	  λ3)	  
Generate	  second	  
primary	  tumor	  and	  
(me	  of	  event	  (λ2)	  
Generate	  primary	  
metastasis	  and	  (me	  
of	  event	  (λ4)	  
Generate	  LR	  of	  second	  
primary	  tumor	  and	  
(me	  of	  event	  (λ3)	  
[if	  second	  primary]	  
Metastasis	  risk	  (λ4)	   Second	  primary	  tumor	  (λ2)	   Local	  recurrence	  risk	  (λ1)	  
age	   tumour	  size	   lymph	  node	  involvement	  
Simula/on	  objec/ve	  
The	   main	   objec(ve	   of	   the	   simula(on	   was	   the	   op(miza(on	   of	  
capacity	   planning	   from	   a	   hospital	   perspec(ve,	   taking	   into	   account	  
the	   heterogeneity	   in	   case	   mix.	   We	   assumed	   the	   number	   of	  
consulta(ons	   to	  be	   the	  op(miza(on	   criterion	  and	  have	   set	   this	   at	  
40	  consults	  throughout	  the	  follow-­‐up	  period.	  
Simula/on	  results	  
	  
Typical	  simula(on	  for	  
one	  group	  of	  pa(ents.	  
Assuming	  a	  threshold	  
Of	  40	  consulta(ons	  per	  
QALY,	  the	  most	  intensive	  
follow-­‐up	  is	  preferred.	  
The	   figure	   presents	   the	   recommended	   follow-­‐up	   scenarios	   for	   all	  





















Red:	  most	  intense	  follow-­‐up	  is	  recommended	  in	  these	  pa(ent	  groups.	  Green:	  least	  intensive	  follow-­‐up	  
may	  be	  recommended	  in	  these	  pa(ent	  groups.	  
	  
Es/mated	  consequences	  
Implementa(on	   of	   the	   follow-­‐up	   recommenda(ons	   may	   be	  
beneficial	   for	   capacity	   planning.	   We	   assumed	   the	   face-­‐to-­‐face	  
interview	  by	  a	  surgeon	  to	  take	  10	  minutes.	  A	  face-­‐to-­‐face	  interview	  
by	  a	  NP	  would	  take	  20	  minutes.	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Impact	  on	  capacity	  planning	  
Several	  follow-­‐up	  scenarios	  may	  be	  evaluated	  on	  the	  ability	  
to	   reduce	   capacity	   for	   breast	   cancer	   follow-­‐up.	   Present	  
guidelines	   result	   in	   nearly	   80,000	   hospital	   visits.	   Changing	  
exis(ng	  Oncoline	  guidelines	  may	  save	  up	  to	  22%	  of	  required	  
capacity.	   However,	   an	   individualized	   approach	   accep(ng	  
max.	   40	   visits	   per	   QALY	   gained	   would	   lead	   to	   about	   70%	  
reduc(on	  in	  required	  capacity.	  
	  
